Cetirizine Hydrochloride Solution
Product Images NDC 61037-479

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Cetirizine Hydrochloride (NDC 61037-479). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bajaj Medical, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Cetirizine Structure)

Chemical structure diagram of cetirizine hydrochloride depicting its molecular framework including chlorine-substituted phenyl rings, piperazine ring, and carboxylic acid functional group.*

FDA Label Image

Ctz-16oz-1 (Ctz 16oz 1)

This text panel for Cetirizine Hydrochloride Syrup 1 mg/mL provides usage instructions and storage conditions. It states the syrup is grape flavored, for oral use only, and details dosage guidance referencing accompanying prescribing information. Storage instructions include room temperature ranges and refrigeration options. The package size noted is 16 fl. oz. (473 mL), labeled Rx only.*

FDA Label Image

Ctz-16oz-2 (Ctz 16oz 2)

Text panels providing detailed clinical pharmacology information for Cetirizine Hydrochloride oral solution 1 mg/mL from Bajaj Medical, LLC. Sections include description, mechanism of action, pharmacokinetics, metabolism, elimination, interaction studies, special populations, and pharmacodynamics.*

FDA Label Image

Ctz-16oz-3 (Ctz 16oz 3)

This image shows the drug information text panel for Cetirizine Hydrochloride oral solution, including sections on clinical studies, indications and usage, contraindications, precautions, drug interactions, carcinogenesis, pediatric use, and adverse reactions. It provides detailed research findings and safety information for healthcare professionals and consumers.*

FDA Label Image

Ctz-16oz-4 (Ctz 16oz 4)

A detailed adverse reactions and safety information panel for cetirizine hydrochloride, including pediatric adverse experiences data in a table comparing placebo and two cetirizine doses. The text covers various body systems affected, post-marketing experience, drug abuse and dependence, and overdose information from clinical trials and post-marketing reports.*

FDA Label Image

Ctz-16oz-5 (Ctz 16oz 5)

This text panel provides dosage and administration information for Cetirizine Hydrochloride oral solution, including dosing recommendations for children aged 6 months to 5 years for chronic urticaria and perennial allergic rhinitis. It describes the syrup as colorless to slightly yellow with grape flavor, details package sizes (4-oz and 16-oz amber plastic bottles), and includes storage instructions. Manufactured by Bajaj Medical, LLC.*

FDA Label Image

Ctz-16oz-6 (Ctz 16oz 6)

Label for Cetirizine Hydrochloride Syrup 1 mg/mL oral solution, grape flavored, manufactured by Bajaj Medical, LLC. The label states it is for oral use, contains 1 mg cetirizine hydrochloride per mL, packaged in a 16 fl. oz. (473 mL) bottle, and is prescription only. Storage instructions and usual dosage guidance are also indicated.*

FDA Label Image

4oz1 (Ctz 4oz 1)

Cetirizine Hydrochloride Syrup 1 mg/mL oral solution label from Bajaj Medical, LLC. The label specifies grape flavor, a 4 fl. oz. (120 mL) bottle size, and storage instructions including temperature ranges and light-resistant container requirement. The label includes an NDC code 61037-479-02 and barcode, with a manufacturing date of 09/2023. Rx only.*

FDA Label Image

4oz2 (Ctz 4oz 2)

This panel contains the description and clinical pharmacology sections for Cetirizine Hydrochloride oral solution. It includes the chemical structure of cetirizine hydrochloride, a summary of its physical properties, inactive ingredients in the syrup, and detailed pharmacologic information including its mechanism of action and pharmacokinetics such as absorption, distribution, and metabolism.*

FDA Label Image

4oz3 (Ctz 4oz 3)

This text panel includes detailed pharmacokinetic and pharmacodynamic information for cetirizine hydrochloride. It covers elimination half-life, interaction studies, special population effects including pediatric patients, and the impact of gender and race on drug kinetics. Additionally, it describes cetirizine's effects in clinical studies on wheal and flare responses, respiratory challenges, and cardiac QTc intervals.*

FDA Label Image

4oz4 (Ctz 4oz 4)

This image displays a text panel containing clinical study summaries and safety information for cetirizine hydrochloride. It covers clinical trial data, indications and usage for perennial allergic rhinitis and chronic urticaria, contraindications, and precautions related to mental alertness while using the medication.*

FDA Label Image

4oz5 (Ctz 4oz 5)

Text panel detailing drug interactions and nonclinical studies related to cetirizine hydrochloride. It covers drug-drug interactions, carcinogenicity, mutagenesis, impairment of fertility, and related research findings in animals, including dosage references and study results.*

FDA Label Image

4oz6 (Ctz 4oz 6)

This panel provides detailed pediatric use and adverse reactions information for cetirizine hydrochloride oral solution. It summarizes clinical trial data on safety, efficacy, dosing, and adverse events in pediatric patients from 6 months to 11 years old, including placebo-controlled studies and comparative reactions in various age groups.*

FDA Label Image

4oz7 (Ctz 4oz 7)

A table presenting adverse experiences reported in pediatric patients aged 6 to 11 years from placebo-controlled cetirizine hydrochloride trials. It compares the frequency of various side effects such as headache, pharyngitis, abdominal pain, coughing, and others between placebo and cetirizine hydrochloride at 5 mg and 10 mg doses. Additional text lists infrequent adverse events observed in adults and children aged 12 years or older.*

FDA Label Image

4oz8 (Ctz 4oz 8)

A text panel showing sections including Vision effects, Body as a Whole, Post-Marketing Experience, Drug Abuse and Dependence, Overdosage, Dosage and Administration, How Supplied, and Storage guidelines for cetirizine hydrochloride syrup. It details side effects, overdose information, dosages for children, storage temperatures, and manufacturer information for Bajaj Medical, LLC, Chicago, IL.*

FDA Label Image

4oz9 (Ctz 4oz 9)

Label for Cetirizine Hydrochloride Syrup 1 mg/mL, an oral solution manufactured by Bajaj Medical, LLC. The label includes NDC 61037-479-02, states it is grape flavored, and contains 4 fl. oz. (120 mL). Storage instructions specify room temperature or refrigeration. The label also notes it is Rx only and includes a barcode and manufacturing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.